Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Àlex Rovira

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2018
Imaging of meningeal inflammation should become part of the routine MRI protocol - CommentaryÀlex Rovira
Neuroimaging Clinics of North America|April 11, 2017
Advances in the Diagnosis, Characterization, and Monitoring of Multiple SclerosisÀlex Rovira
Radiology|September 16, 2025
Diffusion Tensor Imaging Analysis along the Perivascular Space and NeurodegenerationÀlex Rovira, Deborah Pareto
Expert Review of Neurotherapeutics|July 19, 2021
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosisÀlex Rovira, Cristina Auger
Neurology|August 30, 2024
χ-Separation as a Novel MRI Biomarker for Assessing Disease Progression in Multiple Sclerosis: Divide and ConquerÀlex Rovira, Deborah Pareto
Brain Communications|February 7, 2025
Unmasking paramagnetic rim multiple sclerosis lesions: the advantages of quantitative susceptibility mapping over phase imagingÀlex Rovira, Deborah Pareto
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2022
T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis - CommentaryÀlex Rovira, Deborah Pareto
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2025
Reinforcing the evidence framework for paramagnetic rim lesions in MS: Advancing toward broad clinical integrationAlessandro Cagol, Àlex Rovira
European Radiology|November 16, 2023
MRI as a biomarker of the smouldering component of multiple sclerosis: time to wake upÀlex Rovira, Deborah Pareto
AJR. American Journal of Roentgenology|November 17, 2021
Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease ActivityÀlex Rovira, Cristina Auger
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2018
Imaging of meningeal inflammation should become part of the routine MRI protocol - CommentaryÀlex Rovira
Neuroimaging Clinics of North America|April 11, 2017
Advances in the Diagnosis, Characterization, and Monitoring of Multiple SclerosisÀlex Rovira
Radiology|September 16, 2025
Diffusion Tensor Imaging Analysis along the Perivascular Space and NeurodegenerationÀlex Rovira, Deborah Pareto
Expert Review of Neurotherapeutics|July 19, 2021
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosisÀlex Rovira, Cristina Auger
Neurology|August 30, 2024
χ-Separation as a Novel MRI Biomarker for Assessing Disease Progression in Multiple Sclerosis: Divide and ConquerÀlex Rovira, Deborah Pareto
Brain Communications|February 7, 2025
Unmasking paramagnetic rim multiple sclerosis lesions: the advantages of quantitative susceptibility mapping over phase imagingÀlex Rovira, Deborah Pareto
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2022
T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis - CommentaryÀlex Rovira, Deborah Pareto
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2025
Reinforcing the evidence framework for paramagnetic rim lesions in MS: Advancing toward broad clinical integrationAlessandro Cagol, Àlex Rovira
European Radiology|November 16, 2023
MRI as a biomarker of the smouldering component of multiple sclerosis: time to wake upÀlex Rovira, Deborah Pareto
AJR. American Journal of Roentgenology|November 17, 2021
Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease ActivityÀlex Rovira, Cristina Auger
Pageof 17